Homepage

Using simulated scenarios to train front-line staff in the COVID-19 response

The Oxford Simulation, Teaching and Research Centre has been busier than ever during the coronavirus pandemic

COVID-19 drug trial could lead to enhanced respiratory care for patients

Researchers including Stuart McKechnie and Matthew Rowland from our Critical Care Research Group are carrying out a new drug trial aimed at treating COVID-19, funded by LifeArc.

Effects of COVID-19 on sleep: Oxford researchers lead international study

An international group of researchers led by Professor Colin Espie is investigating the impact of the COVID-19 pandemic on sleep and daily rhythms in adults.

Using wearable technology to monitor COVID-19 patients

System being used in John Warin isolation ward at Oxford's John Radcliffe Hospital

Oxford leads part of major COVID-19 drugs trial

As part of the UK NIHR multi-arm, multi-stage CATALYST Trial, researchers at the University of Oxford will investigate whether administering the anti-inflammatory drug infliximab to patients with COVID-19 can prevent progression to respiratory failure or death.

Using MRI to investigate the effect of COVID-19 on the brain

A team of our neuroimaging researchers will lead this study, which has received a grant from the University of Oxford's COVID-19 Research Response Fund.

From our Head of Department

Welcome to the Nuffield Department of Clinical Neurosciences (NDCN), one of the World's leading centres for research and treatment in disorders of the nervous system.

Professor Kevin Talbot

Find out more